From Our Archives

The Cox-2 Inhibitors Controversy

Question and Answer with Dr. William Shiel and Dr. Michael Smith

Dr. Shiel is a a practicing rheumatologist, and Chief Medical Editor of, and Dr. Smith is Senior Medical Editor, WebMD, Inc.

  1. Question: Dr. Smith
    Are Cox-2 inhibitors less likely to irritate the stomach than older antiinflammatory drugs?

    Answer: Dr. Shiel
    Selective Cox-2 inhibitors (such as Celebrex and Bextra) NOTE: April 7, 2005, Pfizer has agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the with the FDA. For more information, please read the FDA press release. , do not inhibit the Cox-1 enzyme in the stomach and are thus felt to be less toxic to the stomach than traditional antiinflammatory drugs (such as aspirin, ibuprofen, or naproxen). These traditional anti-inflammatory drugs, called nonselective Cox-1/Cox-2 inhibitors, inhibit both Cox-1 and Cox-2 enzymes. While inflammation is reduced by blocking Cox-2, the protective mucus lining of the stomach is also reduced when Cox-1 is blocked, which can cause stomach upset, ulcers, and bleeding.